<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Recently, microRNA-124 (miR-124) has been demonstrated as a potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role of miR-124 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>This study was aimed at investigating the clinicopathological significance of miR-124 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Quantitative real-time PCR was used to analyze miR-124 expression in 96 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and individual-matched <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa samples </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of miR-124 was assessed for associations with clinicopathological characteristics using chi-square test </plain></SENT>
<SENT sid="5" pm="."><plain>The survival curves were calculated by the Kaplan-Meier method </plain></SENT>
<SENT sid="6" pm="."><plain>The influence of each variable on survival was examined by the Cox multivariate regression analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The miR-124 expression was significantly downregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> compared to <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P = 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, miR-124 decreased expression correlated significantly with the grade of differentiation (P = 0.021) </plain></SENT>
<SENT sid="9" pm="."><plain>Univariate survival analysis showed that the downregulated miR-124 was significantly correlated with worse prognosis, both in terms of overall survival (P = 0.017) and disease-free survival (DFS) (P = 0.014) </plain></SENT>
<SENT sid="10" pm="."><plain>Further, the downregulated miR-124 was demonstrated as a prognostic factor for overall survival (hazard ratio, HR = 4.634; 95 % confidence interval, CI, 1.731-12.404; P = 0.002) and DFS (HR = 4.533, 95 % CI 1.733-11.856, P = 0.002), independently of gender, age, location, maximum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, depth of invasion, differentiation, and TNM stage </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: MiR-124 may play a certain role in the development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The downregulation expression of miR-124 is an independent prognostic factor in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>